The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Chan, C. W. Y.
Right arrow Articles by Levy, G. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Chan, C. W. Y.
Right arrow Articles by Levy, G. A.
Right arrowPubmed/NCBI databases
*Gene*GEO Profiles
*HomoloGene*UniGene
*Substance via MeSH
The Journal of Immunology, 2003, 170: 4036-4044.
Copyright © 2003 by The American Association of Immunologists

Soluble Fibrinogen-Like Protein 2/Fibroleukin Exhibits Immunosuppressive Properties: Suppressing T Cell Proliferation and Inhibiting Maturation of Bone Marrow-Derived Dendritic Cells1

Camie W. Y. Chan, Lyndsey S. Kay, Rachel G. Khadaroo, Matthew W. C. Chan, Sophia Lakatoo, Kevin J. Young, Li Zhang, Reginald M. Gorczynski, Mark Cattral, Ori Rotstein and Gary A. Levy2

Multi Organ Transplant Program, Toronto General Hospital and University of Toronto, Toronto, Ontario, Canada

Fibrinogen-like protein 2 (fgl2)/fibroleukin is a member of the fibrinogen-related protein superfamily. In addition to its established role in triggering thrombosis, it is known to be secreted by T cells. The soluble fgl2 (sfgl2) protein generated in a baculovirus expression system bound to both T cells and bone marrow-derived dendritic cells (DC) in a specific manner. sfgl2 exhibited immunomodulatory properties capable of inhibiting T cell proliferation stimulated by alloantigens, anti-CD3/anti-CD28 mAbs, and Con A in a dose-dependent manner; however, it had no inhibitory effects on CTL activity. The time- and dose-dependent inhibitory effect of sfgl2 on alloreactive T cell proliferation could be neutralized by a mAb against mouse fgl2. Polarization toward a Th2 cytokine profile with decreased production of IL-2 and IFN-{gamma} and increased production of IL-4 and IL-10 was observed in sfgl2-treated allogeneic cultures. Exposure of immature DC to sfgl2 abrogated the expression of CD80high and MHC class IIhigh molecules and markedly inhibited NF-{kappa}B nuclear translocation, thus inhibiting their maturation. sFgl2-treated DC had an impaired ability to stimulate allogeneic T cell proliferation. Maximal inhibition of proliferation was observed when allogeneic T cells were cultured with sfgl2-treated DC and sfgl2 protein was added in the culture. These data provide the first evidence to demonstrate that sfgl2 exerts immunosuppressive effects on T cell proliferation and DC maturation.




This article has been cited by other articles:


Home page
J. Immunol.Home page
I. Shalev, H. Liu, C. Koscik, A. Bartczak, M. Javadi, K. M. Wong, A. Maknojia, W. He, M. F. Liu, J. Diao, et al.
Targeted Deletion of fgl2 Leads to Impaired Regulatory T Cell Activity and Development of Autoimmune Glomerulonephritis
J. Immunol., January 1, 2008; 180(1): 249 - 260.
[Abstract] [Full Text] [PDF]


Home page
Physiol. GenomicsHome page
J. Mu, D. Qu, A. Bartczak, M. J. Phillips, J. Manuel, W. He, C. Koscik, M. Mendicino, L. Zhang, D. A. Clark, et al.
Fgl2 deficiency causes neonatal death and cardiac dysfunction during embryonic and postnatal development in mice
Physiol Genomics, September 11, 2007; 31(1): 53 - 62.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
T. L. Denning, S. Granger, D. Mucida, R. Graddy, G. Leclercq, W. Zhang, K. Honey, J. P. Rasmussen, H. Cheroutre, A. Y. Rudensky, et al.
Mouse TCR{alpha}beta+CD8{alpha}{alpha} Intraepithelial Lymphocytes Express Genes That Down-Regulate Their Antigen Reactivity and Suppress Immune Responses
J. Immunol., April 1, 2007; 178(7): 4230 - 4239.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
M. Mendicino, M. Liu, A. Ghanekar, W. He, C. Koscik, I. Shalev, M. Javadi, J. Turnbull, W. Chen, L. Fung, et al.
Targeted Deletion of Fgl-2/Fibroleukin in the Donor Modulates Immunologic Response and Acute Vascular Rejection in Cardiac Xenografts
Circulation, July 12, 2005; 112(2): 248 - 256.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
Q. Ning, Y. Sun, M. Han, L. Zhang, C. Zhu, W. Zhang, H. Guo, J. Li, W. Yan, F. Gong, et al.
Role of Fibrinogen-Like Protein 2 Prothrombinase/Fibroleukin in Experimental and Human Allograft Rejection
J. Immunol., June 1, 2005; 174(11): 7403 - 7411.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
G. E. Olson, V. P. Winfrey, S. K. NagDas, and M. H. Melner
Region-specific Expression and Secretion of the Fibrinogen-related Protein, fgl2, by Epithelial Cells of the Hamster Epididymis and Its Role in Disposal of Defective Spermatozoa
J. Biol. Chem., December 3, 2004; 279(49): 51266 - 51274.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
W. W. Hancock, F. M. Szaba, K. N. Berggren, M. A. Parent, I. K. Mullarky, J. Pearl, A. M. Cooper, K. H. Ely, D. L. Woodland, I.-J. Kim, et al.
Intact type 1 immunity and immune-associated coagulative responses in mice lacking IFN{gamma}-inducible fibrinogen-like protein 2
PNAS, March 2, 2004; 101(9): 3005 - 3010.
[Abstract] [Full Text] [PDF]


Home page
Mol Hum ReprodHome page
D. A. Clark, K. Foerster, L. Fung, W. He, L. Lee, M. Mendicino, U. R. Markert, R. M. Gorczynski, P. A. Marsden, and G. A. Levy
The fgl2 prothrombinase/fibroleukin gene is required for lipopolysaccharide-triggered abortions and for normal mouse reproduction
Mol. Hum. Reprod., February 1, 2004; 10(2): 99 - 108.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 2003 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 2003 by The American Association of Immunologists, Inc. All rights reserved.